Ivan Morace is a molecular biologist by education (MSc at the University of Padua, Italy) and after obtaining a PhD in the field of experimental renal pathology and autoimmune diseases (German Cancer Research Center, University of Heidelberg, Germany), he moved to the Venture Capital field and served for 4 years as a Senior Investment Analyst at MediVentures GmbH (2019-2023), where he supported the setting up, strategy and activities of seed to series A investments in Life Sciences and Digital Health European startups. He has also supported portfolio companies in strategy, R&D development and fundraising while also serving as an Advisory Board member at Actitrexx GmbH (2020-2024). After one year spent later in the pharmaceutical sector supporting the Business Development and Medical Affairs activities at MEDICE Arzneimittel Pütter GmbH & Co. KG. he then decided to take the biotechnology entrepreneurial path and created Cerryx in 2024 where he serves as a CEO and Managing Director.